What email address or phone number would you like to use to sign in to Docs.com?
If you already have an account that you use with Office or other Microsoft services, enter it here.
Or sign in with:
Signing in allows you to download and like content, and it provides the authors analytical data about your interactions with their content.
Embed code for: IUIS Advanced Course on Vaccines Dec 2017
Select a size
IUIS-BRAZIL ADVANCED COURSE ON VACCINES Dec 11-15, 2017 PROGRAM SPEAKERS TITLES DAY 1 December 11 8:30-9:00 Credentials and opening 9:00-9:30 Short talk 1 Alexander Precioso, I. Butantan, Brasil Vaccine impact, epidemiology, established vaccines 9:30 -10:15 KEYNOTE TALK 1 Rino Rappuoli, GSK, Italia Vaccine pipeline-from discovery to licensed vaccine 10:15-10:45 Discussion 10:45-11:30 Coffee break 11:30-12:15 KEYNOTE TALK 2 Rino Rappuoli, GSK, Italia Technologies to implement bacterial vaccines 12:15-12:30 Discussion 12:30-14:00 Lunch 15:00-16:30 Student presentations (posters) 16:30-17:00 Coffee break 17:00-18:30 Initiation to grant writing DAY 2 December 12 8:30-9:00 Short talk 2 Paulo Lee Ho, I. Butantan, Brazil Adjuvants: basic concepts, mechanisms of action, importance for vaccine formulation 9:00-9:30 Short talk 3 Helder Nakaya, USP, Brazil Systems vaccinology 9:30 -10:15 KEYNOTE TALK 3 Willem Hanekom, BMGF. EUA Which new vaccines are needed and which vaccines have to be improved? 10:15-10:45 Discussion 10:45-11:30 Coffee break 11:30-13:00 Grant writing session 13:00-14:30 Lunch 14:30-15:00 Short Talk Luiza Guilherme, Heart Institute/USP,Brazil A vaccine against Rheumatic Fever 15:00-15:15 Discussion 15:30-17:00 Student presentations (posters) 17:00-17:30 Coffee break 17:30-18:15 KEYNOTE TALK 4 Steve Whitehead, NIH, EUA Development of a tetravalent attenuated Dengue vaccine 18:15-18:30 Discussion DAY 3 December 13 8:30-9:00 Short talk 4 Alejandro Chabalgoity, Uruguay New approaches for the development of anti-cancer vaccines 9:00-9:30 Short talk 5 Juliana Cassataro, IIB, Argentina Development of a new vaccine adjuvant, study of mechanisms of action and uses thereof 9:30 -10:15 KEYNOTE TALK 5 Ricardo Gazzinelli An alternative platform for an anti-cancer vaccine 10:15-10:45 Discussion 10:45-11:30 Coffee break 11:30-12:15 KEYNOTE TALK 6 Barney Graham Development of HIV vaccines 12:15-12:30 Discussion 12:30-14:00 Lunch 15:00-16:30 Student presentations (posters) 16:30-17:00 Coffee break 17:00-18:30 Grant writing session DAY 4 December 14 8:30-9:00 Short talk 6 Alexis Kalergis, IMII, Chile Translational immunology: basic knowledge aimed at preventing infectious diseases and autoimmunity 9:00-9:30 Short talk 7 Esper Kallás, FMUSP, Brazil Vaccine Clinical Trials 9:30 -10:15 KEYNOTE TALK 7 Ana Paula Fernandes, UFMG, Brazil Development of a Vaccine against Leishmaniasis 10:15-10:45 Discussion 10:45-11:30 Coffee break 11:30-12:15 KEYNOTE TALK 8 Anna Durbin, Johns Hopkins University, EUA Controlled infection models for Dengue and Zika vaccine 12:15-12:30 Discussion 12:30-14:00 Lunch 15:00-16:30 Student presentations (posters) 16:30-17:00 Coffee break 17:00-18:30 Grant writing session December 15 DAY 5 December 15 8:30-9:15 KEYNOTE TALK 9 Fernando Goñi, NYU, USA Vaccines against neurodegenerative diseases 9:15-9:30 Discussion 9:45-10:15 Powerpoint presentation of grant proposals prepared during the course 10:15-10:45 Coffee break 10:45-12:00 Discussion of grant proposals prepared during the course 12:00-12:30 Closing words Jorge Kalil